Remove 2018 Remove Access Remove Events Remove Policy
article thumbnail

2018 at Sensi Seeds – Our Year in Review

Sensi Seeds

January 2018 was a hemp-based month, featuring the launch of our CBD oil capsules and the inauguration of the Hemp Design Villa in Oude Pekela. On a visit to Amsterdam earlier in 2018, they gave a series of video interviews which we published on the blog. June saw events worth celebrating from the whole family of companies.

Hash 75
article thumbnail

Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Cannabis Law Report

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Access to Psychedelic Therapies and Equity in Emerging Psychedelics Industries. Background.

Law 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Special Report: Current Issues in Marijuana Regulation – Veterans Struggle to Gain Access to Medical Marijuana

Cannabis Law Report

Veterans Struggle to Gain Access to Medical Marijuana. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. May 2, 2019.

Access 49
article thumbnail

Nevada NORML: A Year in Review

NORML

With a new year on the horizon, members of Nevada and Las Vegas NORML wanted to take time to shine light on 18 of our most memorable moments from 2018. (It January 2018: Protested Jeff Sessions. February 2018: Dr. Dabber became a sponsor. January – March 2018: Partnering with Harrison House.

Education 106
article thumbnail

AIMS v. Garland: A Disappointment for Psilocybin Advocates, but Progressive Policy May Still be on the Horizon

Cannabis Law Report

Congress passed the RTT Act in 2018 to give qualifying patients access to investigational drugs outside of a clinical trial setting. In response to the DEA’s letter, AIMS, Dr. Aggarwal, and two patients seeking access to psilocybin under the RTT Act filed a lawsuit in the U.S. Enter the Right to Try (RTT) Act. The RTT Act.

DEA 52
article thumbnail

Webinar 9 December: Ethics, Safety, and Abuse in Psychedelic Medicine

Cannabis Law Report

As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Kylea Taylor, M.S., This talk will be recorded and immediately available for rewatch for all attendees.

Safety 52
article thumbnail

FDA and FTC Target Delta-8 Products

Canna Law Blog

You can access the letters here. And if it is derived from hemp, it is not independently scheduled – at least if you read the Controlled Substances Act and 2018 Farm Bill literally. FTC Policy Statement on Deception, 103 F.T.C. Unlike prior rounds of warning letters, these letters have a new focus: harm to children.